Liège, Belgium, 28 May 2018 – Mithra (Euronext Brussels: MITRA), a company specialized in Women’s Health, today provides an update on the progress made with its vaginal contraception ring, Myring™ for the US market.
Share it
Latest news
Mithra reaches milestone in estetrol skin study
8 April 2024
Mithra updates on its ongoing monetization process
28 March 2024